Chronic urticaria: A role for newer immunomodulatory drugs?

American Journal of Clinical Dermatology

Volumn 4, Issue 5, 2003, Pages 297-305

  Tedeschi, Alberto ^a   Airaghi, Lorena ^a   Lorini, Maurizio ^a   Asero, Riccardo ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Clinica San Carlo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; DESLORATADINE; DIPHENHYDRAMINE; EBASTINE; FEXOFENADINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; HYDROXYZINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; METHOTREXATE; MIZOLASTINE; MONTELUKAST; PREDNISONE; SALAZOSULFAPYRIDINE; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN; ZAFIRLUKAST;

CHRONIC URTICARIA; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; OSTEOPOROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; PRURITUS; REVIEW; SEDATION; SIDE EFFECT; STEROID THERAPY; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; CHRONIC DISEASE; CYCLOSPORINE; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOTRIENE ANTAGONISTS; METHYLPREDNISOLONE; SKIN TESTS; URTICARIA;

EID: 0038708234     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304050-00001     Document Type: Review

References (91)

1. Greaves MW. Chronic urticaria. N Engl J Med 1995; 332: 1767-72
2. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105: 664-72
3. Kaplan AP. Chronic urticaria and angioedema. N Engl J Med 2002; 346: 175-9
4. May CD. Are confusion and controversy about food hypersensitivity really necessary? J Allergy Clin Immunol 1985; 75: 329-33
5. Doeglas HMG. Reactions to aspirin and food additives in patients with chronic urticaria including the physical urticarias. Br J Dermatol 1975; 93: 135-44
6. Kaplan AP. Urticaria and angioedema. In: Middleton Jr E, Reed CE, Ellis EF, et al., editors. Allergy: principles & practice. 5th ed., vol 2. St Louis: Mosby-Year book, 1998: 1104-22
7. Zuberbier T, Chantraine-Hess S, et al. Pseudoallergen-free diet in the treatment of chronic urticaria: a prospective study. Acta Derm Venereol 1995; 75: 484-7
8. Pigatto PD, Valsecchi RH. Chronic urticaria: a mystery. Allergy 2000; 55: 306-8
9. Zuberbier T, Pfrommer C, Specht K, et al. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 2002; 109: 343-8
10. Di Campli C, Gasbarrini A, Nucera E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43: 1226-9
11. Sakurane M, Shiotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002; 29: 23-7
12. Wedi B, Kapp A. Helicobacter pylory infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002; 3: 273-82
13. Schnyder B, Hebling A, Pichler WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999; 119: 60-3
14. Habte-Gabr E, Tiruneh M, Hailu M. Chronic urticaria: its relationship to intestinal parasitic infestation and response to antihelmintic drugs: a preliminary study. Ethiop Med J 1977; 15: 9-14
15. Oteifa NM, Moustafa MA, Elgozamy BM. Toxocariasis as a possibile cause of allergic diseases in children. J Egypt Soc Parasitol 1998; 28: 365-72
16. Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria: a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114: 583-90
17. Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988; 90: 213-7
18. Grattan CEH, Francis DM, Hide M, et al. Detection of circulating histamine releasing autoantibodies with functional properties of anti IgE in chronic urticaria. Clin Exp Allergy 1991; 21: 695-704
19. Hide M, Francis DM, Grattan CEH, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604
20. Fiebiger E, Maurer D, Holub H, et al. J. Serum IgG autoantibodies directed against the alpha chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995; 96: 2606-12
21. Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-FcεRIα (α-subunit). J Allergy Clin Immunol 1998; 101: 672-6
22. Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999; 104: 169-72
23. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgE-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002; 109: 114-8
24. Zuberbier T, Henz BM, Fiebiger E, et al. Anti-FcεRIα serum autoantibodies in different subtypes of urticaria. Allergy 2000; 55: 9511-4
25. Stadler BM, Miescher S, Horn M, et al. Allergic manifestations as the results of a conditional autoimmune response. Int Arch Allergy Immunol 2001; 124: 411-3
26. Horn MP, Pachlopnik JM, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-FcεRI alpha autoantibodies? FASEB J 2001; 15: 2268-74
27. Elias J, Boss E, Kaplan AP. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986; 78: 914-8
28. Sabroe RA, Poon E, Orchard GE, et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRIα or anti-IgE autoantibodies. J Allergy Clin Immunol 1999; 103: 484-93
29. Wedi B, Novacevic V, Koerner M, et al. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression: inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552-60
30. Maxwell DL, Atkinson BA, Spur BW, et al. Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol 1990; 86: 759-65
31. Cunningham F. Lipid mediators in inflammatory skin disorders. J Lipid Mediat 1990; 2: 61-74
32. Norris JG, Sullivan TJ. Leukotriene and cytokines in steroid dependent chronic urticaria [abstract]. J Allergy Clin Immunol 1998; 101 (pt 2): S128
33. Irani C, Gordon ND, Zweiman B, et al. Chronic urticaria/angioedema and Graves' disease: coexistence of 2 antireceptor antibody-mediated diseases. J Allergy Clin Immunol 2001; 108: 874
34. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66-71
35. Bar-Sela S, Reshef T, Mekori Y. IgE antithyroid microsomal antibodies in a patient with chronic urticaria. J Allergy Clin Immunol 1999; 103: 1216-7
36. Tedeschi A, Lorini M, Asero R. Anti-thyroid peroxidase IgE in patients with chronic urticaria. J Allergy Clin Immunol 2001; 108: 467-8
37. Asero R, Tedeschi A, Lorini M, et al. Chronic urticaria: clinical and serological aspects. Clin Exp Allergy 2001; 31: 1105-10
38. Greaves MW, O'Donnell BF. Not all chronic urticaria is "idiopathic". Exp Dermatol 1998; 7: 11-3
39. Fagiolo U, Kricek F, Ruf C, et al. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000; 106: 567-72
40. Kermani F, Niimi N, Francis DM, et al. Characterization of a novel mast-cell specific histamine releasing activity in chronic idiopathic urticaria (CIU) [abstract]. J Invest Dermatol 1995; 105: 452
41. Claveau J, Lavoie A, Brunet C, et al. Chronic idiopathic urticaria: possible contribution of histamine releasing factor to the pathogenesis. J Allergy Clin Immunol 1993; 92: 132-7
42. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 446-52
43. Ring J, Brockow K, Ollert M, et al. Antihistamines in urticaria. Clin Exp Allergy 1999; 29 Suppl. 1: 31-7
44. Kalivas J, Breneman D, Tharp D, et al. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 1990; 86: 1014-8
45. Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 1996; 30: 1075-9
46. Finn Jr AF, Kaplan AP, Fretwell R, et al. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999; 103: 1071-8
47. Monroe EW. Loratadine in the treatment of urticaria. Clin Ther 1997; 19: 232-42
48. Lorette G, Giannetti A, Pereira RS, et al. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group. J Eur Acad Dermatol Venereol 2000; 14: 83-90
49. Kalis B. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drugs 1996; 52 Suppl. 1: 30-4
50. Ring J, Hein R, Gauger A. Desloratadine in the treatment of chronic idiopathic urticaria. Allergy 2001; 56 Suppl. 65: 28-32
51. Clough GF, Boutsiouki P, Church MK. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare and itch in human skin. Allergy 2001; 56: 985-8
52. Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol 2002; 54: 51-8
53. Zuberbier T, Greaves MW, Juhlin L. et al. Management of urticaria: a consensus report. J Investig Dermatol Symp Proc 2001; 6: 128-31
54. Chowdhury BA. Chronic urticaria and angioedema. N Engl J Med 2002; 347: 220-1
55. Goldsobel AB, Rohr AS, Siegel SC, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986; 78: 867-73
56. Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981; 68: 262-6
57. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria: a randomised double-blind study. Br J Dermatol 1978; 99: 675-6
58. Bleehen SS, Thomas SE, Greaves MW, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987; 117: 81-8
59. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 1995; 95: 685-93
60. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990; 323: 645
61. Spector S, Tan RA. Antileukotrienes in chronic urticaria [letter]. J Allergy Clin Immunol 1998; 101: 572
62. Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1998; 102: 876-7
63. Chu TJ, Warren MS, Zafirlukast (ACCOLATE®) in the treatment of chronic idiopathic urticaria: a case series [abstract]. J Allergy Clin Immunol 1998; 101 (part 2): S155
64. Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria: a double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001; 31: 1607-14
65. Bensch G, Borish L. Leukotriene modifiers in chronic urticaria. Ann Allergy Asthma Immunol 1999; 83: 348
66. Berkun Y, Shalit M. Successful treatment of delayed pressure urticaria with montelukast. Allergy 2000; 55 (2): 203-4
67. Tedeschi A, Lorini M, Suli C, et al. Successful treatment of chronic urticaria. Allergy 2000; 55: 1097-8
68. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002; 110 (3): 484-8
69. Reimers A, Pichler C, Helbling A, et al. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002; 32 (12): 1763-8
70. Asero R, Tedeschi A, Lorini M. Leukotriene receptors antagonists in chronic urticaria. Allergy 2001; 56: 456-7
71. Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000; 85: 156-7
72. Fradin MS, Ellis CN, Goldfarb MT, et al. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991; 25: 1065-7
73. Toubi E, Blant A, Kessel A, et al. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997; 52: 312-6
74. Barlow RJ, Kobza Black A, et al. Treatment of severe, chronic urticaria with cyclosporin A. Eur J Dermatol 1993; 3: 273-5
75. Grattan CEH, O'Donnel BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br J Dermatol 2000; 143: 365-72
76. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747-55
77. Mouthon L, Kaveri SV, Spalter SH, et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 1996; 104 Suppl. 1: 3-9
78. O'Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in chronic autoimmune urticaria. Br J Dermatol 1998; 138: 101-6
79. Asero R. Are IVIG for chronic unremitting urticaria effective? Allergy 2000; 55: 1099-101
80. Grattan CEH, Francis DM, Slater NGP, et al. Plasmapheresis for severe unremitting chronic urticaria. Lancet 1992; 339: 1078-80
81. Gach JE. Sabroe RA, Greaves MW, et al. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol 2001; 145: 340-3
82. Lopez LR, Davis KC, Kohler PF, et al. The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine-. J Allergy Clin Immunol 1984; 73: 600-3
83. Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991; 88: 964-5
84. Hartmann K, Hani N, Hinrichs R, et al. Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria [letter]. Acta Derm Venereol 2001; 81: 71
85. Boehm I, Bauer R, Bieber T. Urticaria treated with dapsone. Allergy 1999; 54: 765-6
86. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995; 96: 901-5
87. Heymann WR. Chronic urticaria and angioedema associated with thyroid autoimmunity: review and therapeutic implications. J Am Acad Dermatol 1999; 40: 229-32
88. Kandeel AA, Zeid M, Helm T, et al. Evaluation of chronic urticaria in patients with Hashimoto thyroiditis. J Clin Immunol 2001; 21: 335-47
89. Berth-Jones J, Hutchinson PE, Wicks ACB, et al. Chronic urticaria with angioedema controlled by warfarin. BMJ 1988; 297: 1382-3
90. Barlow RJ, Greaves MW. Warfarin in the treatment of chronic urticaria/angiooedema. Br J Dermatol 1992; 126: 415-6
91. Parslew R, Pryce D, Ashworth J, et al. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000; 30: 1161-5